Physician profile
Anika Ackerman
NPI 1326307877
$24,694.33
in general payments reported to CMS, 2019-2025
45 companies · $21K in 2025
The $21K reported for 2025 was more than what 96% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $207 · 2020: $155 · 2021: $68.46 · 2022: $619 · 2023: $1,242 · 2024: $1,148 · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $20K · Food and Beverage: $3,545.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,100.00 |
| Food and Beverage | $3,545.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $20,078.05 | 2019-2025 | Erleada |
| Medtronic, INC. | $513.00 | 2023-2025 | Interstim, Kyphon Express II Kyphopak Tray, Solitaire X |
| Calyxo, INC. | $328.53 | 2024-2025 | Cvac Aspiration System |
| Astellas Pharma US INC | $281.06 | 2021-2024 | Veozah, Myrbetriq |
| Allergan, INC. | $257.89 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $248.36 | 2023-2025 | Gemtesa |
| Tolmar, INC. | $213.51 | 2023-2025 | Jatenzo, Eligard |
| Coloplast Corp | $198.49 | 2023-2025 | Speedicath |
| Abbvie INC. | $180.73 | 2022-2025 | Botox, Lupron Depot |
| Immunitybio, INC. | $173.67 | 2024-2025 | |
| 180 Medical, INC. | $166.91 | 2019-2025 | |
| Caldera Medical, INC | $160.42 | 2023 | Desara |
| Ferring Pharmaceuticals INC. | $158.28 | 2024 | Adstiladrin |
| C. R. Bard, INC. & Subsidiaries | $145.89 | 2023-2025 | Purewick Female External Catheter, Bard Urinary Drainage Bag |
| Olympus America INC. | $134.84 | 2022-2025 | Soltive, Itind System |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $120.16 | 2021-2024 | Xyosted |
| Axonics, INC. | $116.69 | 2020-2024 | Bulkamid, Axonics |
| Vectivbio Ag | $100.00 | 2023 | |
| Edap Technomed INC | $100.00 | 2023 | |
| Neotract INC. | $97.89 | 2020 | |
| Teleflex LLC | $80.48 | 2023-2025 | Urolift, Barrigel |
| Endo Pharmaceuticals INC. | $77.83 | 2022-2023 | Aveed, Xiaflex |
| Kowa Pharmaceuticals America, INC. | $72.37 | 2022-2023 | Seglentis |
| Endo USA, INC. | $67.40 | 2024-2025 | Xiaflex, Aveed |
| Bayer Healthcare Pharmaceuticals INC. | $49.15 | 2019-2023 | |
| Photocure INC | $48.11 | 2019-2023 | Cysview |
| Ethicon US, LLC | $48.02 | 2019-2025 | Echelon Flex |
| Agiliti Surgical, INC. | $46.86 | 2023 | Trinity, Sonablate |
| Acerus Pharmaceuticals Corporation | $45.00 | 2022 | |
| Boston Scientific Corporation | $43.09 | 2023-2025 | General - Female Sui |
| Bluewind Medical | $39.76 | 2024-2025 | |
| Bioprotect Medical, INC. | $36.63 | 2024 | Bioprotect Balloon Implant System |
| Corcept Therapeutics | $34.50 | 2019-2024 | Korlym |
| Amag Pharmaceuticals, INC. | $30.71 | 2019 | |
| Pfizer INC. | $30.54 | 2019-2024 | |
| Procept Biorobotics Corporation | $22.17 | 2023 | Aquabeam Robotic System |
| Progenics Pharmaceuticals, INC. | $21.11 | 2025 | |
| Civco Medical Instruments | $19.20 | 2023 | |
| Myriad Genetic Laboratories, INC. | $18.00 | 2022 | |
| Urogen Pharma, INC. | $16.58 | 2023 | Jelmyto |
| Merck Sharp & Dohme LLC | $14.99 | 2019 | |
| Dendreon Pharmaceuticals LLC | $14.96 | 2019 | |
| Zyla Life Sciences, INC. | $14.94 | 2019 | |
| Urovant Sciences INC | $14.17 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $13.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anika Ackerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.